These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29545845)

  • 21. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
    Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
    Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
    Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
    J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.
    Shi Y; Li Y; Yan C; Su H; Ying K
    Oncol Lett; 2019 Dec; 18(6):5859-5870. PubMed ID: 31788059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-malarial drug dihydroartemisinin downregulates the expression levels of
    Hao L; Li S; Peng Q; Guo Y; Ji J; Zhang Z; Xue Y; Liu Y; Shi X
    Oncol Lett; 2021 Sep; 22(3):653. PubMed ID: 34386075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of key genes and pathway related to chemoresistance of small cell lung cancer through an integrative bioinformatics analysis.
    Zeng FR; Zhou XY; Zeng LG; Sun JC; He F; Mo W; Wen Y; Wang SY; Liu Q; Guo LL
    Ann Transl Med; 2022 Sep; 10(18):968. PubMed ID: 36267705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanism of estrogen-mediated neuroprotection in the relief of brain ischemic injury.
    He J; Gao Y; Wu G; Lei X; Zhang Y; Pan W; Yu H
    BMC Genet; 2018 Jul; 19(1):46. PubMed ID: 30029590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of potential key genes in very early hepatocellular carcinoma.
    Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
    World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of key genes in non-small cell lung cancer by bioinformatics analysis.
    Zhang L; Peng R; Sun Y; Wang J; Chong X; Zhang Z
    PeerJ; 2019; 7():e8215. PubMed ID: 31844590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma.
    Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ
    Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis.
    Wang M; Wang L; Wu S; Zhou D; Wang X
    Int J Genomics; 2019; 2019():3518378. PubMed ID: 31886163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microarray-Based Gene Expression Analysis Identifies Potential Diagnostic and Prognostic Biomarkers for Waldenström Macroglobulinemia.
    Xu H; Yao F
    Acta Haematol; 2018; 140(2):87-96. PubMed ID: 30227405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis.
    Wang W; Wang S; Pan L
    Exp Ther Med; 2020 Oct; 20(4):3720-3732. PubMed ID: 32855723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct Molecular Mechanisms Analysis of Three Lung Cancer Subtypes Based on Gene Expression Profiles.
    Wang L; Pei Y; Li S; Zhang S; Yang Y
    J Comput Biol; 2019 Oct; 26(10):1140-1155. PubMed ID: 31305128
    [No Abstract]   [Full Text] [Related]  

  • 37. Candidate genes and pathways associated with brain metastasis from lung cancer compared with lymph node metastasis.
    Zhao X; Wang N; Chidanguro T; Gu H; Li Y; Cao H; Wen P; Ren F
    Exp Ther Med; 2019 Aug; 18(2):1276-1284. PubMed ID: 31363372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of differentially expressed protein-coding genes in lung adenocarcinomas.
    Wang L; Li S; Wang Y; Tang Z; Liu C; Jiao W; Liu J
    Exp Ther Med; 2020 Feb; 19(2):1103-1111. PubMed ID: 32010276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the potential crucial genes in invasive ductal carcinoma using bioinformatics analysis.
    Li C; Luo L; Wei S; Wang X
    Oncotarget; 2018 Jan; 9(6):6800-6813. PubMed ID: 29467930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the anticancer effects of a novel proteasome inhibitor, ixazomib, on colorectal cancer using a combined method of microarray and bioinformatics analysis.
    Fan Q; Liu B
    Onco Targets Ther; 2017; 10():3591-3606. PubMed ID: 28790851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.